National Philanthropic Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Buy
2,734
+393
+17% +$73.9K 0.01% 298
2026
Q1
$462K Hold
2,341
﹤0.01% 285
2025
Q4
$430K Hold
2,341
﹤0.01% 288
2025
Q3
$359K Buy
2,341
+669
+40% +$101K ﹤0.01% 250
2025
Q2
$234K Hold
1,672
﹤0.01% 264
2025
Q1
$246K Hold
1,672
﹤0.01% 244
2024
Q4
$219K Hold
1,672
﹤0.01% 256
2024
Q3
$260K Buy
1,672
+7
+0.4% +$1.13K ﹤0.01% 221
2024
Q2
$260K Sell
1,665
-519
-24% -$78.1K 0.01% 227
2024
Q1
$296K Sell
2,184
-550
-20% -$72.8K 0.01% 228
2023
Q4
$368K Buy
+2,734
New +$355K 0.01% 228

Other funds holding AZN

National Philanthropic Trust's AZN Position: Q2 2026 in Review

National Philanthropic Trust increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $73.9K and bringing the position to 2,734 shares worth $518K. The position accounts for 0.01% of the portfolio, ranked #298.

National Philanthropic Trust first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • National Philanthropic Trust held 2,734 shares of AstraZeneca worth $518K as of Q2 2026.
  • National Philanthropic Trust bought 393 AstraZeneca shares in Q2 2026, an estimated $73.9K.
  • AstraZeneca made up 0.01% of National Philanthropic Trust's portfolio in Q2 2026, its #298 holding.
  • National Philanthropic Trust first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • 1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.